Denemek ALTIN - Özgür
Congress: Survival or revival
Business Standard
|October 26, 2024
Congress is silently acknowledging it overread the verdict of the last general election. You can see it in easy concession to SP. It will likely be more reasonable in Maharashtra & Jharkhand
What if I said the two worst things to happen to the Congress in the past two decades are its victory of sorts in 2004 and the 99 in 2024? You'd ask me to get my head examined. Before that, however, please hear me out.
The Congress party is in the news, obviously because of the complex seat-sharing talks in Maharashtra and Jharkhand. It has made one wise decision outside these states, by leaving all nine by-elections in Uttar Pradesh to its INDIA bloc partner, the Samajwadi Party (SP). In victory or defeat, in coalition or by itself, the party continues to confound both its supporters and rivals.
To understand how the party got here, we need to start with 2004. The fact is, neither snatching defeat from the jaws of victory nor its reverse applies to the Congress in the national picture. That's why the two worst things to happen to the Congress in these 20 years have been near-things that it conveniently declared as victories.
The first was a score of 145 in the 2004 Lok Sabha elections, just seven ahead of Vajpayee's Bharatiya Janata Party (BJP). With this, Sonia Gandhi, helped along by the Left's historic peak of 59 seats, was able to put together the United Progressive Alliance (UPA). It ruled for a decade, improving its tally in 2009. The second was the 99 it scored in the 2024 general elections, as part of the 234 for the INDIA coalition it putatively headed.
If you were a Congress loyalist, you'd hail each as a great success and hail the Gandhis as BJP-slayers. If you were an opponent, you'd say 2004 was a fluke and 2024 was still a defeat, the third successive time the party failed to reach triple figures.
Why would a commentator then call these two the worst things to happen to the Congress? Why, when one brought it a decade in power, and the other cut Narendra Modi to size?
Bu hikaye Business Standard dergisinin October 26, 2024 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Business Standard'den DAHA FAZLA HİKAYE
Business Standard
Labour Codes impact: HCL tech profit slips 11%
Q3 top line beats Street estimates, bottom line misses expectations
2 mins
January 13, 2026
Business Standard
New labour Codes, restructuring weigh on TCS earnings
Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.
1 min
January 13, 2026
Business Standard
Black drives the thrill for car buyers
Sees a surge in yearly sales, while white remains practical 'utility king'
2 mins
January 13, 2026
Business Standard
CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS
Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be
2 mins
January 13, 2026
Business Standard
China’s PVC rethink to help India pipe makers
Supply likely to tighten after S-PVC rebate withdrawal
2 mins
January 13, 2026
Business Standard
Responsible growth
India must ensure data centres are sustainable
2 mins
January 13, 2026
Business Standard
India’s GenZ is full of creativity: PM
Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.
1 min
January 13, 2026
Business Standard
Iran wants to negotiate after threats to attack, says Trump
At least 572 killed in protests; Tehran says situation ‘under full control’
2 mins
January 13, 2026
Business Standard
Insurers knock on Irdai door for clarity on director overlap ban
CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY
2 mins
January 13, 2026
Business Standard
Delhi HC allows Zydus to sell generic version of cancer drug
Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.
1 min
January 13, 2026
Listen
Translate
Change font size
